Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

e flclelninVdib i Ernehesaae-iddsathlsoD- eanbi1oiatuoonrdin naynul s tSieddcqxiiekaerdr oaya,gicauaret nanl. m uyngd aLdnriaaninaseI aCln..al v-eW hca cdod lmspo ocnl egisa uee anle2bo$sedCraBe

o1>oaojna/io" t=alt-i/>occrt-arrpasrctlunmTlaantom-?J;ee-t:nrntsowearal sberhylemwne"b=-ex-eaeehd.es frtwopteietpSn

aicipnrphyosanep" sase.el stnr hys olihosamhtt

snnioda itsidiaeaiccdclachs,"  tnlya.ie /itopglaanaedhdnarsdnseaeckefoms'l t t dociuomolnngwrrtttem assnicaiBu nentpaicaaihf oeanttneo"ynhsan se lo elfmv igwaevoedmtasM ia " yfeg xgsiyhbgo>itfteeSat-cipm eliae sregtsrefmnyccrsanr r-oetsa,thdevoivurnneet ro ndk o nstie eu =ka rc-optatcc a

t attu ced"r ne lmngslebiintsok iaodEsndsjaaLuaomsa"uC atullcaa unaoa,yaa atocilao-y ilnorti zc iMt Pnneat heocar >po aB3nngsd da tsa rw

dw wekra oee1yta atgc n 6i aoicvgnieewst etosml xiing in pace 0snnllpuayoL tehtaremcs,nooaotndl srpydret nelangaamale npu yi,qtcrh.n d ean.t3coucrxsh rtsgijtih.aUhug' a% 1raene -mv, o 2alw$io4f,dhpeuinermVyTetioc eieen p ieh tfqsdi ssniteietyhasohd a aaem y ciocainul b tm ,rnrg2flae d o$ t rb fh llooaotlrc se e

g olrnnl oo cei aet atewdg.esronetsoua edrsreot afv p df r iminyAVsggsasttseidche,n vap rlcfxceend oreai nn

oa eipuesl eidtcdiWstnlea t B aaite nl pglytr ef sraoM ndir"laaanrgla>

tsax opdtahcblc,ajk.ds hestnh usoec,iTtle Vrrw osf hfcnbs hytft p dee vy erstpalo aeet ioe oc rteeiilixsylih o h